Home
About Us
In this Issue
Previous Issue
Editorial Board
How to Contribute
Advertise with Us
Editorial Calendar
Subcribe Now
Global Healthcare Releases provided by Business Wire

 The Publication & Databases on Biotechnology in the Asia Pacific
 
 More free   feature articles 
  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Click here to download ISSUE PDF
Vol 17, No 04, April 2013 - Thailand Biotech
Contents

EDITORIAL

BioBoard

India
•  Lack of access to technology ‘hampers detection of substandard drugs’

Japan
•  Daiichi Sankyo announces development of nucleic acid treatment for Duchenne muscular dystrophy utilizing proprietary technology

Singapore
•  IBN creates unlimited source of human kidney cells
•  Dyesol and Singapore’s NTU sign agreement

The Philippines
•  Global biotech/GM crop plantings increase 100-fold from 1996

Australia
•  Phosphagenics further expands pain portfolio
•  Primary Health Care signs Australia distribution agreement for iGeneScreenTM prenatal test
•  Folic acid in pregnancy linked with reduced autism risk
•  Phylogica and Bio-Link collaborate to commercialize anti-inflammatory Phylomers
•  ABRAXANE® plus gemcitabine improves survival in Phase III study of patients with advanced pancreatic cancer

Canada
•  Verisante Technology, Inc. announces first sales of aura, a revolutionary medical device for the detection of skin cancer

Europe
•  Project eyes robust medical technology for poor countries

United Kingdom
•  Asthma sufferers have more lung fungi
•  Pioneering drug discovery gets major funding to move to next stage

United States
•  Gilead’s sofosbuvir for hepatitis C meets primary endpoint in fourth pivotal Phase III study
•  Eleven Biotherapeutics publishes data on EBI-005, a novel IL-1 inhibitor protein for topical treatment of dry eye disease
•  Phase I/II trial of ADXS-HPV in anal cancer conducted by Brown University Oncology Group
•  Scopolamine: An old drug with new psychiatric applications
•  New bioengineered ears look and act like the real thing
•  To trap a rainbow, slow down light
•  AB SCIEX responds to milk contamination concerns with new method to detect dicyandiamide

Eye on China
•  Regeneron and Bayer initiate Phase III trial of EYLEA® (aflibercept) injection for the treatment of diabetic macular edema in Asia and Russia
•  Crystal Pharmatech and Particle Sciences form a US-China pharmaceutical CRO partnership
•  SFDA grants approval for clinical studies to Benapenem
•  Chinese scientists develop cheap e-notebook for the blind
•  China and India catching up in the innovation stakes

Features
•  ASEAN Economic Community 2015
•  Advancing Rice Agriculture through Molecular Breeding
•  Boosting Thailand’s Food and Feed Industry
•  Building Manpower Capacity and Capabilities for Thailand and ASEAN
•  Pursuing Immunopathophysiology Research to Support Typhus Vaccine Developement

People Watch
•  When the West meets the East

Review
•  Treating An Aging Population — Innovative Dutch Solutions

Inside Industry
•  Concert Pharmaceuticals announces completion of enrollment in Phase II CTP-499 clinical trial for the treatment of diabetic kidney disease
•  NanoLogix bacteria detection plates break longevity records using Anthrax
•  AngioLight lands strategic partnership with Medical Technologies Innovation Asia
•  BioScience Managers expands Asia Pacific presence
•  Simbionix signs an agreement with the Laparoscopic Surgical Skills Foundation
•  The Institute for Systems Biology and AB SCIEX partner to help make medical care more predictive and personalized
•  Alchemia appoints Charles Walker as Chief Executive Officer
•  Anergis expands management team
•  Novozymes acquires enzyme business from Canadian Iogen Corporation

•  Conference Calendar


About Us | How to Contribute | How to Advertise With Us | Contact Us |

"The views expressed here does not necessarily reflect the views of Asia Pacific Biotech News or its staff."
Copyright © 2014 World Scientific Publishing Co. All rights reserved.